Gene expression of prostaglandin EP4 receptor in three canine carcinomas
Abstract Background Chronic inflammation mediated by the cyclooxygenase enzymes, specifically their product prostaglandin E2 (PGE2), can result in the development of cancer. PGE2 promotes cell proliferation, apoptosis, and angiogenesis through interaction with its specific receptors (EP1 receptor -...
Main Authors: | Margaret L. Musser, Austin K. Viall, Rachel L. Phillips, Jesse M. Hostetter, Chad M. Johannes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12917-020-02431-2 |
Similar Items
-
Identification of prostaglandin receptors in human ureters
by: Oll Matthias, et al.
Published: (2012-12-01) -
Changing prostaglandin E2 (PGE2) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE2 receptor EP2 and EP4
by: Qingqing Huang, et al.
Published: (2022-01-01) -
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
by: Anna Semmlinger, et al.
Published: (2018-04-01) -
Immunolocalization of Prostaglandin E2 Receptor Subtype 4 (EP4) in the Cervix of Cyclic Bitches and Those with Pyometra
by: P Linharattanaruksa1, K Chatdarong1, S Ponglowhapan1, M Khalid3 and S Srisuwatanasagul2*
Published: (2013-07-01) -
The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus
by: Asheebo Rojas, et al.
Published: (2014-10-01)